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Mycoplasma suis antigens recognized during humoral immune
response in experimentally infected pigs
Abstract
Today, serodiagnostic tests for Mycoplasma suis infections in pigs have low accuracies. The
development of novel serodiagnostic strategies requires a detailed analysis of the humoral immune
response elicited by M. suis and, in particular, the identification of antigenic proteins of the agent. For
this study, indirect enzyme-linked immunosorbent assay (ELISA) and immunoblot analyses were
performed using pre- and sequential postinoculation sera from M. suis-infected and mock-infected
control pigs. M. suis purified from porcine blood served as the antigen. Eight M. suis-specific antigens
(p33, p40, p45, p57, p61, p70, p73, and p83) were identified as targets of the immunoglobulin G (IgG)
antibody response during experimental infection, with p40, p45, and p70 being the preferentially
recognized M. suis antigens. Besides the M. suis-specific antigens, porcine immunoglobulins were
identified in blood-derived M. suis preparations. By immunoglobulin depletion, the specificity of the M.
suis antigen for use in indirect ELISA was significantly improved. M. suis-specific Western blot and
ELISA reactions were observed in all infected pigs by 14 days postinfection at the latest and until week
14, the end of the experiments. During acute clinical attacks of eperythrozoonosis, a derailment of the
antibody response, determined by decreases in both the M. suis net ELISA values and the numbers of
M. suis-specific immunoblot bands, was accompanied by peaking levels of autoreactive IgG antibodies.
In conclusion, the M. suis-specific antigens found to stimulate specific IgG antibodies are potentially
useful for the development of novel serodiagnostic tests.
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Today, serodiagnostic tests for Mycoplasma suis infections in pigs have low accuracies. The development of
novel serodiagnostic strategies requires a detailed analysis of the humoral immune response elicited byM. suis
and, in particular, the identification of antigenic proteins of the agent. For this study, indirect enzyme-linked
immunosorbent assay (ELISA) and immunoblot analyses were performed using pre- and sequential postin-
oculation sera fromM. suis-infected and mock-infected control pigs.M. suis purified from porcine blood served
as the antigen. Eight M. suis-specific antigens (p33, p40, p45, p57, p61, p70, p73, and p83) were identified as
targets of the immunoglobulin G (IgG) antibody response during experimental infection, with p40, p45, and
p70 being the preferentially recognized M. suis antigens. Besides the M. suis-specific antigens, porcine immu-
noglobulins were identified in blood-derivedM. suis preparations. By immunoglobulin depletion, the specificity
of the M. suis antigen for use in indirect ELISA was significantly improved. M. suis-specific Western blot and
ELISA reactions were observed in all infected pigs by 14 days postinfection at the latest and until week 14, the
end of the experiments. During acute clinical attacks of eperythrozoonosis, a derailment of the antibody
response, determined by decreases in both the M. suis net ELISA values and the numbers of M. suis-specific
immunoblot bands, was accompanied by peaking levels of autoreactive IgG antibodies. In conclusion, the M.
suis-specific antigens found to stimulate specific IgG antibodies are potentially useful for the development of
novel serodiagnostic tests.
Mycoplasma suis (formerly Eperythrozoon suis) belongs to a
group of hemotrophic bacteria which have recently been re-
classified within the genus Mycoplasma (16, 17, 18, 19, 22, 29).
M. suis is an epicellular hemoparasite that attaches to and
causes deformity and damage to porcine erythrocytes (32). The
resulting disease, traditionally called porcine eperythrozoo-
nosis (PE), has been reported worldwide and is considered a
problem of feeder pigs, where it manifests as a febrile acute
icteroanemia with low morbidity and high mortality (8). Chronic
low-grade M. suis infections vary from asymptomatic infections
to a range of clinical conditions, including (i) anemia, mild
icterus, and general unthriftiness in newborns, (ii) growth re-
tardation in feeder pigs, and (iii) poor reproductive perfor-
mance in sows (3, 8, 34). Moreover, M. suis is suspected of
suppressing the host’s immune response, leading to an in-
creased proneness to infection with other infectious agents of
porcine respiratory and enteric diseases (33).
The lack of an in vitro cultivation system is the crucial
barrier to systematic analyses of the biology of M. suis as well
as the development of valuable diagnostic procedures for, e.g.,
the accurate assessment of the prevalence and significance of
M. suis in pig populations (5, 20). Hitherto, laboratory diagno-
sis of M. suis usually relies on the microscopic examination of
chemically stained peripheral blood smears to directly visualize
the microorganisms attached to erythrocytes (15). Recently
established PCR assays for M. suis can detect acutely diseased
animals and also asymptomatic carrier pigs and are therefore
principally suitable tools for the diagnosis of PE (6, 10, 15).
However, PCR-based methods are still restricted to special-
ized, well-equipped research laboratories.
Methods to detect carrier animals are important for inves-
tigating the epidemiology of M. suis infections. For these pur-
poses, serological assays are still the methods of choice. A
specific and sensitive serological assay based on defined M. suis
antigens would allow extensive prevalence studies and be ap-
plicable as a matter of routine in diagnostic laboratories. How-
ever, attempts to analyze the humoral immune response of pigs
to M. suis have been impeded by the poor sensitivities and
specificities of current antibody assays, which comprise the
complement fixation test, the indirect hemagglutination assay,
and the enzyme-linked immunosorbent assay (ELISA) (2, 12,
25, 26, 27, 28). Serodiagnostic assays described so far have the
intrinsic disadvantage of employing complex and undefined M.
suis antigens obtained from the peripheral blood of experimen-
tally infected pigs.
Analogous to M. pneumoniae respiratory infection in hu-
mans as well as M. synoviae and M. gallisepticum infections in
chickens, M. suis is capable of transiently inducing in swine the
expression of cold-reactive antierythrocyte autoantibodies
known as cold agglutinins (CA) (21, 24, 33). CA are of the
immunoglobulin M (IgM) isotype and are directed against
carbohydrate antigens expressed on the erythrocyte surface (7,
21, 33). The biological activities of CA are considered directly
responsible for pathogenic effects in PE such as acrocyanosis
and pallor and probably also for a suppressive effect on T-
lymphocyte blastogenic responses (33). In the blood of exper-
imentally infected pigs, CA and M. suis-specific antibodies
appear simultaneously (33). As a result, CA may interfere with
the identification of M. suis-specific serum antibodies by ELISAs,
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which are still dependent on using blood-derived M. suis anti-
gens. In these assays, CA bound to stray erythrocyte membrane
residues in the blood-derived crude antigen would be targeted
by secondary anti-swine immunoglobulin antibody conjugates,
thereby masking M. suis-specific reactivities (25). This fact may
limit the validity of serological diagnostic methods. Moreover,
the lack of knowledge about the M. suis antigens which are
recognized during infection has surely delayed the develop-
ment of improved serodiagnostic tests.
The present study was aimed at detecting immunogenic pro-
teins expressed by M. suis during infection. For this purpose,
we analyzed in detail the antibody response to M. suis during
experimental infections of pigs.
MATERIALS AND METHODS
Mycoplasma suis strain and experimental inoculum. The M. suis strain, 54/96,
used in this study originated from a pig suffering from strong acute PE. The strain
was maintained in splenectomized piglets (10 to 12 weeks of age) by subsequent
artificial infection as described elsewhere (10). For use as an inoculum in exper-
imental infections, blood was collected from the cranial vena cavae of M. suis-
infected pigs during heavily parasitemic clinical attacks of PE, as confirmed by
microscopic examination of acridine orange-stained peripheral blood smears.
Alsever’s solution was used as an anticoagulant (111.0 mM glucose, 27.2 mM
sodium citrate, 71.8 mM sodium chloride, pH 6.1). Blood samples were diluted
at a 1:1 ratio with Alsever’s solution and stored in 4.0-ml volumes at 80°C.
Three piglets confirmed free of M. suis by repeated microscopic examination
of acridine orange-stained peripheral blood smears as well as by PCR ac-
cording to established methods were used as blood donors for a negative
control inoculum (10).
Animals and experimental design. The experimental study was approved by
the government of Upper Bavaria under registration number 211-2531-77/98 and
was performed in compliance with animal care legal prescriptions. Sixty German
White-Landrace cross piglets (12 weeks old, 26 to 34 kg) were included in the
study. Piglets were born from sows without any history of clinical PE and con-
firmed negative for M. suis by means of PCR and peripheral blood microscopy
(10). Animals were allocated into three groups (groups I to III; 20 piglets per
group) on a randomly stratified basis. Groups were housed in isolated but
identical pens. Animals were provided a commercial pellet diet and water ad
libitum and were subjected to the same environmental and managerial condi-
tions throughout the study. Animals in group I (negative controls) were splenec-
tomized 21 days prior to inoculation with the M. suis-negative control inoculum.
Animals in group II were splenectomized 21 days prior to inoculation with M.
suis, and group III consisted of unsplenectomized piglets inoculated with M. suis.
On day 0 (3 weeks after splenectomy), piglets were inoculated intramuscularly
with 2.0 ml of either the M. suis-negative control inoculum (group I) or the M.
suis inoculum (groups II and III) as described elsewhere (10, 32, 33). Animals
were monitored daily for any signs of illness throughout the study. In cases of
severe clinical PE attacks, repeated administration of tetracycline (20 to 30
mg/kg of body weight) was necessary. All animals were bled by venipuncture at
weekly intervals, commencing 1 week prior to primary infection, for 15 weeks.
Serum samples were stored at 20°C.
Mycoplasma suis antigen. M. suis-infected whole blood was obtained from
experimentally infected blood donor animals at maximum bacteremia from acute
clinical PE. Two hundred milliliters of peripheral whole blood was collected in
200 ml Alsever’s solution at a 1:1 ratio. M. suis cells were purified as described
previously (10). In order to further purify M. suis cells from host cell components,
the resulting M. suis pellet was resuspended in sterile phosphate-buffered saline
and was further purified by centrifugation through 20% sodium diatrozoat me-
glumine and diatrozoat sodium (76% Urografin; Schering, Berlin, Germany) at
25,000 g for 1 h at 4°C (1). The final pellet was suspended in 1.0 ml phosphate-
buffered saline and stored at 80°C until use (M. suis antigen). A negative
control antigen was accordingly prepared from anticoagulated blood of three
noninfected animals which were confirmed as free of M. suis as described above.
Depletion of albumin and IgG from antigens. Depletion was done using a
ProteoExtract albumin/IgG removal kit (VWR Life Science, Luzerne, Switzerland)
according to the manufacturer’s instructions. Briefly, 50 l of M. suis or control
antigen (100 g total protein each) was diluted 10-fold with binding buffer.
Diluted samples were added to and allowed to pass through an equilibrated resin
bed by gravity flow. The flowthrough was collected. The columns were washed
with 600 l binding buffer. The combined fractions (flowthrough of the sample
and wash fraction) represent the albumin/IgG-depleted antigens. Protein con-
centrations of antigens were determined by the Lowry method (14).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot
analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was per-
formed according to standard procedures (13), using 10.0% polyacrylamide gels
and a protein loading concentration of 8.0 g per track. Separated proteins were
transferred onto nitrocellulose membranes (31) using a semidry electrophoretic
transfer cell (Trans Blot; Bio-Rad). Immunoblots were probed with sera from
experimental piglets (diluted 1:100). A slot blot device (Multi-Screen apparatus;
Bio-Rad) was applied to analyze serial serum samples from eight pigs randomly
selected from group II. Immunoreactive proteins were visualized by using horse-
radish peroxidase-labeled goat anti-pig IgG (heavy-plus-light-chain [HL]
specific; Sigma), goat anti-pig IgG ( chain specific; KPL-Bioreba, Reinach,
Switzerland), and goat anti-pig IgM ( chain specific; KPL) as secondary anti-
bodies, with 4-chloro-1-naphthol as the chromogenic reagent. Protein bands
were sized with reference to molecular size marker lanes (prestained molecular
size standard, 16.5 to 175 kDa; Bioconcept, Allschwil, Switzerland), using a
computer-aided bioimaging system (BioProfil 3.1; LTF, Wasserburg, Germany).
ELISA. ELISAs were performed as previously described (11). Briefly, micro-
titer plates were coated with 40 ng per well of antigen (M. suis antigen, with and
without IgG depletion, or negative control antigen, with and without IgG deple-
tion). Incubations with serum dilutions (1:100) and horseradish peroxidase-
conjugated goat anti-swine IgG (HL-chain specific; Sigma) were performed for
1 h. Antigen-antibody reactions were visualized with ABTS [2,2-azinobis(3-
ethylbenzthiazolinesulfonic acid); Roche] according to the manufacturer’s rec-
ommendations. Optical densities (OD) were measured at 405 nm by a computer-
assisted microplate reader (Tecan). Cutoff values were calculated for each
microtiter plate from mean OD values for seven negative serum samples ran-
domly selected from group I animals according to the method of Tijssen (30).
Statistical analysis. Statistical analysis was performed with SigmaStat soft-
ware, version 3.0 (SPSS Inc., Chicago, IL). The statistical significance of the
differences between the medians of separate groups was determined by Kruskal-
Wallis analysis of variance (ANOVA) on ranks. P values of 0.05 were consid-
ered significant.
RESULTS
Antigen reactivity. To determine the antigenicities of M. suis
proteins, Western blot analyses were performed on a panel of
convalescent-phase sera from M. suis-infected pigs. Using M.
suis antigen, these sera exhibited distinct reactivities with 11
proteins ranging from 27 to 83 kDa in size (p27, p33, p40, p45,
p56, p57, p61, p70, p73, p77, and p83). In contrast, only two
proteins (p27 and p56) were detected in the control antigen
(Fig. 1). Sera from noninfected pigs showed strong reactions
with p27, p56, and p77 in the M. suis antigen and weak reac-
tions with p27 and p56 in the control antigen (Fig. 1). Notably,
protein bands for p27, p56, and p77 were also reactive with the
anti-pig IgG conjugate (HL chain specific) in controls for
nonspecific binding (no serum samples; Fig. 1). Using subclass-
specific anti-pig IgG and IgM antibodies, p56 and p77 were
identified as heavy chains of IgG and IgM, respectively. Band
p27 was identified as the light chain of immunoglobulins based
on its molecular mass and selective immunoreactivity: it was
positive with the HL-chain-specific conjugate and negative
with subclass H chain-specific conjugates (data not shown).
These findings confirm that 8 of the 11 seroreactive proteins
are specific for M. suis.
M. suis ELISA. The results shown in Fig. 1 indicate that
porcine immunoglobulins are a common impurity of the M.
suis antigen. In ELISAs, these immunoglobulins may display a
marked ability to bind the secondary antibody, thus interfering
with the detection of M. suis-specific antibodies. Figure 2A
illustrates that sera from M. suis-negative control pigs (nega-
tive sera) as well as the anti-pig IgG conjugate alone exhibited
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considerable ELISA reactivities with both the M. suis antigen
and the control antigen (OD405, 1.797 0.083 to 1.870 0.128
[mean values  standard deviations]). ELISA reactivities of
sera from M. suis-infected pigs (positive sera) with the control
antigen ranged around the same level (1.909  0.133). The
differences in the mean values among these five groups were
not statistically significant (Fig. 2A; P 	 0.412). In contrast,
ELISA reactivities of positive sera with M. suis antigen exhib-
ited OD values with an average of 2.304  0.166. These values
significantly exceeded the cutoff value of 1.961 calculated from
OD measures of negative sera with M. suis antigen as well as
the OD mean values obtained for reactions of positive sera
with the control antigen (P  0.001). Taken together, the data
indicate that the ELISA using M. suis and control antigen
allows for the identification of M. suis-specific antibodies de-
spite the substantial background levels due to the inherent
binding of secondary antibody to porcine immunoglobulin res-
idues in both antigens.
In order to determine the extent to which these immuno-
globulin residues bind the secondary antibody, M. suis and
control antigens were depleted of immunoglobulins and com-
paratively analyzed under the same ELISA conditions. Figure
2B demonstrates that the depletion of immunoglobulins from
the antigens led to a significant reduction in nonspecific ELISA
reactions. OD values for positive sera, negative sera, and the
conjugate alone with the depleted control antigen declined by
an average of 93.5% compared with OD values measured with
the undepleted control antigen (P 0.001). These results were
paralleled by a significant drop of 93.9% (on average) in OD
values for negative sera and the conjugate with the depleted M.
suis antigen (P  0.001). On the other hand, even though the
mean ELISA response level of positive sera with the M. suis
antigen was also significantly lowered due to depletion, by
17.1% (P  0.05), the remaining mean OD level for positive
sera with depleted M. suis antigen (1.909  0.216) was nearly
15-fold higher than the corresponding values for all control
reactions (positive sera versus depleted control antigen or neg-
ative sera and conjugate versus both depleted antigens). These
data support the idea that the M. suis-specific analytical ELISA
sensitivity can be remarkably enhanced by a preceding deple-
tion of immunoglobulins from the antigens. This appreciable
improvement in sensitivity was also expressed by a significantly
reduced cutoff OD value of 0.130 due to the depletion of
immunoglobulins from the antigens, in contrast to 1.961 using
undepleted antigens.
Antibody response kinetics. Western blotting and ELISA
were performed on a total of 120 serum samples obtained from
FIG. 1. Western blots prepared with blood-derived M. suis antigen
(lanes 1, 3, and 5) and with blood from a noninfected healthy pig (lanes
2, 4, and 6) were incubated with convalescent-phase serum (lanes 1 and
2), serum from a noninfected healthy pig (lanes 3 and 4), and the
anti-pig IgG conjugate (lanes 5 and 6). In lane 1, arrows indicate eight
M. suis-specific antigens, i.e., 33-, 40-, 45-, 57-, 61-, 70-, 73-, and 83-kDa
proteins. Empty arrows indicate bands of immunoglobulin origin (27,
56, and 77 kDa) copurified from the blood of an M. suis-infected pig
(lane 1) and a noninfected healthy pig (lane 2). Immunoglobulin bands
were also detected if M. suis antigen and negative control antigen were
incubated with either blood serum from a noninfected healthy pig
(lanes 3 and 4) or the anti-pig IgG conjugate alone (lanes 5 and 6).
Lane M, molecular weight standard; molecular masses in kilodaltons
are indicated on the left.
FIG. 2. Depletion of immunoglobulin is essential for measuring M.
suis-specific antibodies in sera from experimentally infected pigs.
ELISA responses of sera from M. suis-infected pigs and noninfected
healthy control pigs and of the anti-pig IgG conjugate alone were
measured against untreated antigens (A) and antigens depleted of
porcine immunoglobulin (B). Each bar represents the mean (plus
standard deviation) of ELISA values from five individuals. , P  0.05
(one-way ANOVA). Ms antigen, M. suis antigen.
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eight experimentally infected pigs between days 0 and 98. A
representative Western blot is shown in Fig. 3. All preinfection
sera were negative for M. suis-specific reactivities on the im-
munoblots. M. suis-specific antibodies were detected as early as
1 week postinfection, and all pigs were identified as antibody
responders within 3 weeks postinfection. Band reactivities for
the postinfection sera were highly variable (Table 1). Three
proteins, i.e., p40, p45, and p70, were detected as early as 7 to
14 days postinfection and remained the preferentially recog-
nized antigens even in the late stage of infection. These obser-
vations suggested that antibodies against these three antigens
might serve as useful markers for a past infection with M. suis.
Further antigens recognized by most animals by days 56 to 63
were p33, p61, and p83.
Figure 4 shows representative kinetics of the antibody re-
sponse obtained by ELISA. M. suis antibodies were not found
in any of the sera taken at housing and prior to inoculation.
After experimental infection, M. suis-specific antibodies signif-
icantly increased from week 1 to week 2. This significance was
maintained for the remainder of the experiment compared to
the day 0 control. For all pigs, ELISA OD values peaked
around attacks of acute PE, and these increases were observed
with both M. suis and control antigens. Strikingly, these mark-
edly peaking ELISA values were consistently correlated with a
FIG. 3. Kinetic immunoblot analysis of antibody response following experimental M. suis infection (pig no. 96/99). Western blots of blood-
derived M. suis antigens were probed with sequential sera collected weekly before inoculation (lane P) and weeks after infection (lanes 1 to 14)
with M. suis. Filled arrows on the right indicate the locations of the immunodominant M. suis antigens (p70, p45, and p40). The positions of
coreactive immunoglobulins extracted from porcine blood during antigen processing are marked (empty arrows) and indicate bands of 27 and 56
kDa. Arrows on the bottom indicate the time points of clinical PE attacks (weeks 5 and 7).
TABLE 1. Antibody reactions of experimental animals to M. suis antigens
M. suis-specific
protein
No. of animals reacting to antigen at indicated time (wk postinfection)
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
p83 0 0 1 1 0 0 0 1 4 6 4 5 7 5 4
p73 0 0 0 1 1 1 0 3 3 2 3 5 5 3 5
p70 0 0 3 5 7 6 7 7 3 6 6 7 7 7 8
p61 0 0 0 1 0 2 3 3 3 8 5 7 5 3 3
p57 0 0 1 4 2 1 1 0 3 4 3 5 4 3 3
p45 0 1 5 7 8 7 4 4 4 7 6 7 7 6 6
p40 0 2 6 8 8 7 7 7 8 8 8 8 8 8 7
p33 0 0 1 4 3 2 1 3 5 6 4 6 5 4 5
p31 0 0 0 2 3 2 1 2 2 2 2 2 4 5 3
No. of reactive
pigs
0 2 7 8 8 8 8 8 8 8 8 8 8 8 8
Avg no. of bands
detected
0 1.5 2.4 4.1 4.0 3.5 3.0 3.8 4.4 6.1 5.1 6.5 6.5 5.5 5.5
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substantial decrease in the number of seroreactive M. suis
proteins on the immunoblots (Fig. 4).
Figure 5 shows a detailed analysis of ELISA and Western
blot results obtained for sera from eight pigs during clinical PE
attacks compared to sera taken 1 week before and 1 week after
the PE attacks. During PE attack, both the M. suis-specific
antibodies detected by ELISA (net OD for M. suis 	 OD with
M. suis antigen  OD with control antigen) and the number of
M. suis-specific immunoblot bands were significantly decreased
in comparison to the values found 1 week before and 1 week
after the attack. In parallel, the concentration of antibodies
highly cross-reacting with the control antigen significantly in-
creased during the PE attack (P 0.001). Subsequent analyses
showed that these antibodies belonged to the immunoglobulin
subclasses IgG (95%) and IgM (5%).
Western blot and ELISA reactivities of clinically defined
sera. To prove the diagnostic feasibility of Western blotting and
ELISA, specified experimental porcine sera were investigated.
Serum samples taken 3 weeks after experimental infection from
20 nonapparently M. suis-infected pigs (group III) and from 20
clinically diseased pigs (group II, acute PE at 
6 to 10 days
postinfection) consistently showed M. suis-specific Western blot
reactivities with at least p40, p45, or p70. This M. suis-specific
antibody response was also consistently detected by ELISA, using
antigens depleted of residual immunoglobulins. OD values
ranged between 0.339 and 2.215. Serum samples from mock-
infected pigs (group I, n 	 20) exhibited no M. suis-specific sero-
reactivities in Western blots and ELISAs (data not shown).
DISCUSSION
In order to understand more thoroughly the antibody re-
sponse against M. suis, we sought to characterize M. suis-
specific antigens in blood-derived preparations of the agent.
For this, we modified our recently published protocol for gain-
ing M. suis DNA by a density gradient centrifugation step that
was described to efficiently separate hemotrophic mycoplasmas
from erythrocytic membranes (1). The results of our Western
blot studies show that M. suis expresses in vivo at least eight
specific proteins, ranging from 33 to 83 kDa in size, which are
recognized by convalescent-phase sera. To the best of our
knowledge, this is the first analysis of M. suis-specific antigens.
Due to the use of host-derived M. suis antigens, the antibody
response measured is expected to exclusively target antigens
expressed by M. suis within the porcine host. However, it is
impossible at this time to conceive any precise function for
these proteins.
Of particular note is the consistent detection of three pro-
tein bands (p27, p56, and p77) in immunoblots of sera from
infected and uninfected pigs as well as in conjugate control
blots. Using subclass-specific conjugates, p56 and p77 were
identified as heavy chains of IgG or IgM, and p27 was identi-
fied as the light chain of immunoglobulins. These immuno-
globulins are copurified from the blood and are components of
the positive (p27, p56, and p77) and negative (p27 and p56)
antigen preparations. Thus, M. suis antigen contains large
amounts of IgM antibodies induced by acute M. suis infection
which cannot be detected in control antigens derived from the
blood of healthy pigs.
Using blood-derived antigens in a similar study of feline M.
hemofelis infection, Alleman and coworkers (1) were able to
identify a 56-kDa antigen which showed significant seroreac-
tivities with both initial and follow-up serum samples. The
FIG. 5. Changes in the antibody response during acute PE attacks.
ELISA OD values (Y1 axis) and Western blot reactivities (Y2 axis) were
analyzed for a total of 10 acute PE attacks in eight experimentally M.
suis-inoculated pigs. The M. suis-specific OD values were normalized
by subtraction of control antigen OD values at each time point. Im-
munoblot responses were monitored by enumerating M. suis-specific
antigen bands and are expressed as means and standard deviations.
Standard deviations are shown by error bars. For acute PE attacks, OD
values of autoreactive antibodies and M. suis-specific antibodies as well
as the mean number of M. suis-specific Western blot reactive bands
were significantly different from corresponding pre- and postattack
values (, P  0.05 [one-way ANOVA]). These data evidence an
interrelation between the increase in autoreactive antibodies and the
decrease in M. suis-specific antibodies during PE attacks. Ms antigen,
M. suis antigen.
FIG. 4. Representative kinetic ELISA analysis of the antibody re-
sponse following experimental M. suis infection. Sequential sera from
an M. suis-infected pig (pig no. 94/99) collected pre- and postinocula-
tion were incubated with blood-derived immunoglobulin-depleted M.
suis and control antigens. Optical densities (OD, Y1 axis) were com-
pared with Western blot reactivities (Y2 axis, numbers of seroreactive
M. suis-specific antigen bands). Note that distinct M. suis-specific se-
roreactivities were detectable during asymptomatic stages of infection.
During clinical attacks of PE (weeks 7 and 12, indicated by arrows),
peaking ELISA reactivities with both the M. suis and control antigens
are associated with decreases in Western blot reactivities. Ms antigen,
M. suis antigen.
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authors postulated that this p56 antigen originated from feline
erythrocytes. However, it is plausible from our studies using
commercially available immunoglobulins (data not shown) that
p56 represents the heavy chain of the IgG molecule. Thus,
immunoglobulins should be taken into consideration as con-
taminants of blood-derived M. suis preparations. Our attempts
to remove immunoglobulins from the M. suis antigen by using
a commercially available immunoglobulin depletion kit were
successful. In contrast to the case with undepleted M. suis
antigen, only slight ELISA reactivities due to anti-swine IgG
conjugate binding (equivalent to normal ELISA background
blank levels) remained after immunoglobulin depletion. As a
consequence, we can conclude that the depletion of immuno-
globulins is an important step forward to increase the specific-
ity of host-derived M. suis antigens. This finding led us to
further analyze the kinetics of the M. suis antibody response in
experimentally infected pigs by means of an indirect ELISA
with depleted antigens.
In representative kinetics of the M. suis antibody responses,
as demonstrated by Western blotting, sequential sera from
infected pigs reacted with M. suis-specific bands within 2 weeks
postinfection, and this antibody response persisted until the
termination of the experiment. From immunoblot result anal-
ysis, some features should be pointed out. First, the antibody
response during PE involves multiple antigens and is charac-
terized by temporal and animal-to-animal variations in antigen
recognition. This highly heterogeneous antigen recognition
may reflect either host immune response variability or differ-
ences in infection progression. These findings should be ad-
dressed in future studies. Second, it is noteworthy that three of
eight seroreactive antigens, i.e., p40, p45, and p70, were pref-
erentially involved in the antibody response since all infected
pigs showed distinct seroreactivities with at least one of these
proteins during the second week of infection, and these per-
sisted until the end of the experiment. We therefore concluded
that antibodies against these three antigens can serve as useful
markers for a past infection with M. suis. Finally, it must be
pointed out that compared to the case for serum samples from
subclinical phases of PE, the number of seroreactive M. suis-
specific protein bands was significantly reduced for serum sam-
ples taken during clinical PE attacks. Since p40 reactivity in the
sera persisted even through the clinical PE attacks, we propose
using this protein as an antigen in ELISAs.
In parallel, we monitored serum IgG antibody levels against
either M. suis or control antigen by indirect ELISA. All ani-
mals developed a strong antibody response against M. suis by 8
to 10 days postinfection at the earliest and until the end of the
experiment at 14 weeks. These findings are consistent with a
functional humoral immune response, and consequently, we
reasoned that the high levels of antibodies specifically targeting
the M. suis antigen are strongly related to active M. suis infec-
tion. Most importantly, vigorous ELISA IgG peaks with both
M. suis and control antigens were recorded for all animals
during all clinical attacks of PE observed throughout the entire
experiment. Thus, on the one hand, the ELISA using immuno-
globulin-depleted blood-derived M. suis antigens has proven
valid for detecting antibodies against M. suis during the asymp-
tomatic stage of PE and is therefore suitable as a screening
assay to identify carrier animals. However, on the other hand,
the detection of M. suis-specific antibodies by indirect ELISA
fails during clinical attacks of PE due to the fact that high levels
of autoreactive antibodies mask lowered levels of M. suis antibod-
ies. The immunoglobulin kinetics, as measured by ELISA, agree
with earlier findings of the fundamental study of Zachary and
Smith (33) showing that clinical attacks of PE go along with
peaks of hyperglobulinemia in pig serum due to a polyclonal
B-lymphocyte activation. Notably, our study extends the find-
ings of Zachary and Smith (33), i.e., that acute PE is also
associated with a polyclonal increase in IgG antibodies and
that these antibodies are obviously autoreactive to normal con-
stituents of the porcine blood. Moreover, parallel analyses of
ELISA and Western blotting results evidenced a striking in-
verse correlation between IgG antibodies that are autoreactive
with porcine blood components and M. suis-specific antibodies.
Of course, the reasons for the temporal interrelation between
the increase in the autoreactive antibody response and the
significant drop in the number of seroreactive M. suis protein
antigens, as recognized by immunoblotting, are clearly open to
speculation at this point.
The increase in autoreactive IgG is directly associated with
maximal bacteremia and clinical symptoms, whereas serum
levels of anti-erythrocyte CA IgM increase afterwards (33).
The M. suis-induced anti-erythrocyte CA IgM may arise in
response to a modification of carbohydrate antigens on the
erythrocytic cell surface as a result of intimate membrane in-
teractions between M. suis and erythrocytes and is suggested to
contribute to clinical symptoms, i.e., the appearance of pallor
and acrocyanosis via cold agglutination (32). In contrast, the
mechanisms by which M. suis initiates the production of auto-
reactive IgG antibodies during acute clinical PE are currently
unknown. Members of the genus Mycoplasma, including patho-
genic species associated with diseases of animals, are known to
present a variety of structures capable of engaging both innate
and adaptive components of the immune system (4, 9). For
instance, a series of studies have revealed that mycoplasmas
possess potent B-cell mitogens capable of stimulating a poly-
clonal activation and proliferation of B cells, resulting in the
production of polyclonal immunoglobulin, some of which may
be autoreactive (4, 23). However, the development of M. suis-
induced autoreactive IgG antibodies and their role in the
pathogenesis of PE remain to be determined.
In conclusion, we provide here the first report of M. suis-
specific protein antigens. Among these, three immunodomi-
nant proteins with apparent molecular masses of 40, 45, and 70
kDa were consistently recognized in Western blots by sera
from experimentally infected animals. The finding that the
specificities of blood-derived M. suis preparations increased
significantly after the depletion of immunoglobulins could im-
prove the serodiagnosis of PE by indirect ELISA. Our ELISA
studies of the M. suis-induced antibody response revealed a
distinct specific antibody response alongside a nonspecific re-
sponse of probably autoreactive IgG antibodies due to poly-
clonal B-cell proliferation during clinical PE attacks. Finally, it
is anticipated that the M. suis proteins demonstrated in this
study will be evaluated in detail as antigens leading to the
development of novel serodiagnostic tests for M. suis.
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